Search

everythinglearnresearchcommunity

for

Search:↓

Antibiotics can reduce acne but may lead to resistant bacteria, and understanding the skin's bacteria is important for treatment.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

ABCG2 protein marks stem-like skin cells in human epidermis.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

Drug repositioning can save time and money but needs more support.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

Innovative methods are reducing animal testing and improving biomedical research.

Gentamicin penetrates pig skin better through open hair follicles than blocked ones.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.